These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21346407)

  • 1. [Cautions in usage of generic epinastine].
    Watanabe N; Nakagawa T; Sano Y; Makino S
    Arerugi; 2011 Jan; 60(1):51-2. PubMed ID: 21346407
    [No Abstract]   [Full Text] [Related]  

  • 2. Epinastine ophthalmic solution (Elestat).
    Med Lett Drugs Ther; 2004 Apr; 46(1181):35-6. PubMed ID: 15114254
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine.
    Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Asakura M; Matsumura R; Itoh M
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():64-9. PubMed ID: 8750798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged nocturnal penile tumescence caused by epinastine.
    Yamanaka M; Kitamura M; Iwasa A; Koga M; Matsumiya K; Okuyama A
    Int J Urol; 1999 Mar; 6(3):162-3. PubMed ID: 10226830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers.
    Schilling JC; Adamus WS; Kuthan H
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):493-7. PubMed ID: 1982280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects.
    Pradhan S; Abhishek K; Mah F
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1135-40. PubMed ID: 19630694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
    Tasaka K; Kamei C; Nakamura S
    Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
    Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
    Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
    Leroy T; van Neste D
    Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition.
    Kamei C; Akagi M; Mio M; Kitazumi K; Izushi K; Masaki S; Tasaka K
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):191-205. PubMed ID: 1375955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
    Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinastine in the management of ocular allergic disease.
    Friedlaender MH
    Int Ophthalmol Clin; 2006; 46(4):85-6. PubMed ID: 17060794
    [No Abstract]   [Full Text] [Related]  

  • 14. Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis.
    Trattler WB; Luchs J; Majmudar P
    Int Ophthalmol Clin; 2006; 46(4):87-99. PubMed ID: 17060795
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
    Misawa M; Kanai Y
    Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of epinastine on chemokine production and MHC class II/CD54 expression in keratinocytes.
    Kobayashi M; Kabashima K; Tokura Y
    J Dermatol Sci; 2007 Feb; 45(2):144-6. PubMed ID: 17070018
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of pharmacological properties of optical isomers and a racemic mixture of epinastine.
    Tasaka K; Kamei C; Izushi K; Tsujimoto S; Yoshida T
    Arzneimittelforschung; 1991 Mar; 41(3):219-23. PubMed ID: 1714277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice.
    Villareal AL; Farley W; Pflugfelder SC
    Eye Contact Lens; 2006 Dec; 32(6):272-6. PubMed ID: 17099387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of granulocytes in the lung and skin of guinea pigs. Inhibition by the anti-H1 antiallergic agent epinastine.
    Fügner A; Meissner C
    Arzneimittelforschung; 1994 Dec; 44(12):1338-42. PubMed ID: 7848354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epinastine 0.05% ophthalmic solution in contact lens-wearing subjects with a history of allergic conjunctivitis.
    Nichols KK; Morris S; Gaddie IB; Evans D
    Eye Contact Lens; 2009 Jan; 35(1):26-31. PubMed ID: 19125045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.